Impact of neoadjuvant therapy on prognosis in renal cell carcinoma with inferior vena cava thrombus
Highlight • Neoadjuvant therapy significantly improved DFS and OS in RCC patients with IVC thrombus. • Patients receiving neoadjuvant therapy had a 2-year recurrence-free survival of 70.9%. • Pathological complete…